205 related articles for article (PubMed ID: 11121637)
1. Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas.
Fuss M; Debus J; Lohr F; Huber P; Rhein B; Engenhart-Cabillic R; Wannenmacher M
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1381-7. PubMed ID: 11121637
[TBL] [Abstract][Full Text] [Related]
2. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution.
Combs SE; Volk S; Schulz-Ertner D; Huber PE; Thilmann C; Debus J
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):75-81. PubMed ID: 16111574
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy in patients with vestibular schwannoma and neurofibromatosis type 2: clinical results and review of the literature.
Wagner J; Welzel T; Habermehl D; Debus J; Combs SE
Tumori; 2014; 100(2):189-94. PubMed ID: 24852864
[TBL] [Abstract][Full Text] [Related]
4. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.
Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J
Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiotherapy for the treatment of acoustic neuromas.
Selch MT; Pedroso A; Lee SP; Solberg TD; Agazaryan N; Cabatan-Awang C; DeSalles AA
J Neurosurg; 2004 Nov; 101 Suppl 3():362-72. PubMed ID: 15537191
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for neurological complications after acoustic neurinoma radiosurgery: refinement from further experiences.
Ito K; Shin M; Matsuzaki M; Sugasawa K; Sasaki T
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):75-80. PubMed ID: 10924974
[TBL] [Abstract][Full Text] [Related]
7. Fractionated stereotactic radiotherapy for acoustic neuroma: single-institution experience at The Princess Margaret Hospital.
Koh ES; Millar BA; Ménard C; Michaels H; Heydarian M; Ladak S; McKinnon S; Rutka JA; Guha A; Pond GR; Laperriere NJ
Cancer; 2007 Mar; 109(6):1203-10. PubMed ID: 17318817
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of fractionated stereotactic radiotherapy for acoustic neuromas.
McClelland S; Gerbi BJ; Higgins PD; Orner JB; Hall WA
J Neurooncol; 2008 Jan; 86(2):191-4. PubMed ID: 17622486
[TBL] [Abstract][Full Text] [Related]
9. Five-year outcomes following hypofractionated stereotactic radiotherapy delivered in five fractions for acoustic neuromas: the mean cochlear dose may impact hearing preservation.
Chen Z; Takehana K; Mizowaki T; Uto M; Ogura K; Sakanaka K; Arakawa Y; Mineharu Y; Miyabe Y; Mukumoto N; Miyamoto S; Hiraoka M
Int J Clin Oncol; 2018 Aug; 23(4):608-614. PubMed ID: 29556918
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated CyberKnife stereotactic radiosurgery for acoustic neuromas with and without association to neurofibromatosis Type 2.
Ju DT; Lin JW; Lin MS; Lee LM; Tseng HM; Wei CP; Yen CH; Hung CC; Hung KS; Lin CM; Lin TJ; Chiu WT; Tsai JT
Acta Neurochir Suppl; 2008; 101():169-73. PubMed ID: 18642654
[TBL] [Abstract][Full Text] [Related]
11. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.
Kruyt IJ; Verheul JB; Hanssens PEJ; Kunst HPM
J Neurosurg; 2018 Jan; 128(1):49-59. PubMed ID: 28128697
[TBL] [Abstract][Full Text] [Related]
12. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of stereotactic radiosurgery (SRS) in patients with acoustic neuromas.
Combs SE; Thilmann C; Debus J; Schulz-Ertner D
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1341-7. PubMed ID: 16464537
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiotherapy for vestibular schwannomas: favorable outcome with minimal toxicity.
Chan AW; Black P; Ojemann RG; Barker FG; Kooy HM; Lopes VV; McKenna MJ; Shrieve DC; Martuza RL; Loeffler JS
Neurosurgery; 2005 Jul; 57(1):60-70; discussion 60-70. PubMed ID: 15987541
[TBL] [Abstract][Full Text] [Related]
15. Reduced-dose fractionated stereotactic radiotherapy for acoustic neuromas: maintenance of tumor control with improved hearing preservation.
Champ CE; Shen X; Shi W; Mayekar SU; Chapman K; Werner-Wasik M; Farrell CJ; Gunn V; Downes MB; Liu H; Evans JJ; Andrews DW
Neurosurgery; 2013 Sep; 73(3):489-96. PubMed ID: 23756743
[TBL] [Abstract][Full Text] [Related]
16. Fractionated stereotactic radiotherapy for acoustic neuromas: a prospective monocenter study of about 158 cases.
Litre F; Rousseaux P; Jovenin N; Bazin A; Peruzzi P; Wdowczyk D; Colin P
Radiother Oncol; 2013 Feb; 106(2):169-74. PubMed ID: 23219253
[TBL] [Abstract][Full Text] [Related]
17. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
[TBL] [Abstract][Full Text] [Related]
18. Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients.
Boari N; Bailo M; Gagliardi F; Franzin A; Gemma M; del Vecchio A; Bolognesi A; Picozzi P; Mortini P
J Neurosurg; 2014 Dec; 121 Suppl():123-42. PubMed ID: 25434946
[TBL] [Abstract][Full Text] [Related]
19. Analyses of neuro-otological complications after radiosurgery for acoustic neurinomas.
Ito K; Kurita H; Sugasawa K; Mizuno M; Sasaki T
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):983-8. PubMed ID: 9392535
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiosurgery and radiotherapy for acoustic neuromas.
Kalogeridi MA; Kougioumtzopoulou A; Zygogianni A; Kouloulias V
Neurosurg Rev; 2020 Jun; 43(3):941-949. PubMed ID: 30982152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
